We noticed you're using an older browser.

If you have trouble accessing the referral forms please click HERE and for the best experience we suggest using one of the following options:

Potentially promising Alzheimer's drug going forward

A drug created by the company Biogen might be able to slow the progression of Alzheimer's Disease.

The company initially discontinued work on aducanumab when it started with disappointing results. They now say that a further analysis of that same data has actually suggested it may decrease cognitive loss in its treatment of Alzheimer's Disease.

Dr. Andrew Frank speaks with Rob Snow on 580 CFRA

Dr. Andrew Frank of Bruyère spoke about it yesterday on CFRA. Dr. Frank suggests further trials will be necessary, but that this remains a positive development in the world of dementia.

RECOMMENDED POSTS

Client Story: Bill Hayden

By Alexandra Peach "For a diagnosis, see a neurologist, for the other 99% of your well-being, see the Dementia Society."Bill Hayden, person living with dementia Five years ago, as a multi-tasking senior executive at a life science informatics company, ...

COVID-19 Client Immunization Policy

The Dementia Society loves seeing you at our free events! After successfully moving many programs online at the beginning of the pandemic, we are now reopening some in-person activities and programs in compliance with Ontario’s ...

Give 65 Campaign – July 13-16, 2021

July 13-16 marks the date for the next Give65 Event. Through our partnership with GIVE65, a Home Instead Senior Care Foundation of Canada program, the Dementia Society could benefit from up to $5,000 in additional matching grants. Matching dollars are ...

CONNECT WITH COACH
MAKE A REFERRAL
For Professionals
INVITE A SPEAKER
VOLUNTEER
Submit a Form
magnifiercrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram